107 related articles for article (PubMed ID: 26072217)
21. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
Sun F; Fu H; Liu Q; Tie Y; Zhu J; Xing R; Sun Z; Zheng X
FEBS Lett; 2008 Apr; 582(10):1564-8. PubMed ID: 18406353
[TBL] [Abstract][Full Text] [Related]
22. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma.
Kim BK; Kim I; Yoon SK
J Dermatol Sci; 2015 Aug; 79(2):137-47. PubMed ID: 26026896
[TBL] [Abstract][Full Text] [Related]
23. p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.
Zhang Q; Cao LY; Cheng SJ; Zhang AM; Jin XS; Li Y
Oncol Rep; 2015 Mar; 33(3):1335-41. PubMed ID: 25591821
[TBL] [Abstract][Full Text] [Related]
24. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.
Zhu X; Li Y; Xie C; Yin X; Liu Y; Cao Y; Fang Y; Lin X; Xu Y; Xu W; Shen H; Wen J
Int J Cancer; 2014 Sep; 135(6):1286-96. PubMed ID: 24510775
[TBL] [Abstract][Full Text] [Related]
25. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
[TBL] [Abstract][Full Text] [Related]
26. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
27. Poly r(C) binding protein is post-transcriptionally repressed by MiR-490-3p to potentiate squamous cell carcinoma.
Xia S; Zhao Z; Xie F; He J; Li H
Tumour Biol; 2016 Nov; 37(11):14773-14778. PubMed ID: 27629145
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
29. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.
Liu G; Sun Y; Ji P; Li X; Cogdell D; Yang D; Parker Kerrigan BC; Shmulevich I; Chen K; Sood AK; Xue F; Zhang W
J Pathol; 2014 Jul; 233(3):308-18. PubMed ID: 24604117
[TBL] [Abstract][Full Text] [Related]
30. 1α,25 dihydroxi-vitamin D₃ modulates CDK4 and CDK6 expression and localization.
Irazoqui AP; Heim NB; Boland RL; Buitrago CG
Biochem Biophys Res Commun; 2015 Mar; 459(1):137-42. PubMed ID: 25721671
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.
Tang LH; Contractor T; Clausen R; Klimstra DS; Du YC; Allen PJ; Brennan MF; Levine AJ; Harris CR
Clin Cancer Res; 2012 Sep; 18(17):4612-20. PubMed ID: 22761470
[TBL] [Abstract][Full Text] [Related]
32. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
Yamane K; Jinnin M; Etoh T; Kobayashi Y; Shimozono N; Fukushima S; Masuguchi S; Maruo K; Inoue Y; Ishihara T; Aoi J; Oike Y; Ihn H
J Mol Med (Berl); 2013 Jan; 91(1):69-81. PubMed ID: 22828925
[TBL] [Abstract][Full Text] [Related]
35. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
36. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
37. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance.
Cornell L; Wander SA; Visal T; Wagle N; Shapiro GI
Cell Rep; 2019 Mar; 26(10):2667-2680.e7. PubMed ID: 30840889
[TBL] [Abstract][Full Text] [Related]
39. Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.
Wang X; Sistrunk C; Rodriguez-Puebla ML
Am J Pathol; 2011 Jan; 178(1):345-54. PubMed ID: 21224071
[TBL] [Abstract][Full Text] [Related]
40. HuR promotes miRNA-mediated upregulation of NFI-A protein expression in MDSCs during murine sepsis.
Bah I; Alkhateeb T; Kumbhare A; Youssef D; Yao ZQ; Hawkin GA; McCall CE; El Gazzar M
Mol Immunol; 2020 Jul; 123():97-105. PubMed ID: 32474254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
